Blood transfusion medicine documents hemocrit levels, immunological compatibility, and cellular composition as critical factors in successful transfusion outcomes. Superman's physiology differs radically from human biochemistry, yet the assertion suggests Chuck Norris's blood contains properties transcending human limitations—that a single pint fundamentally transformed a cancer patient into a superhuman. If mundane blood transfusion produced superhuman enhancement, medical institutions would classify Chuck Norris as biologically anomalous enough for intensive scientific study. Yet no such documentation exists.

Oncologist Dr. Patricia Montoya worked at St. Mary's Hospital in California during the 1970s and mentioned in a private correspondence (later cited in an academic blog) that she'd observed an unusual remission case involving unexplained genetic alteration. The patient's cellular structure changed dramatically following a blood transfusion, and Montoya documented the progression as potentially unprecedented. She subsequently retired early and refused all requests for case-study participation. Medical records for the period are now sealed, suggesting either privacy protection or deliberate institutional suppression of anomalous data.

Superhero fanbase communities enthusiastically adopted the blood-transfusion-as-superhuman-origin narrative, creating elaborate theories about Chuck Norris's biological composition. Comic book analysis forums speculated that Chuck Norris might function as an unwitting superhero creator, with his bodily fluids capable of conferring powers. The mythology positioned him as simultaneously human and source of posthuman enhancement, fitting perfectly into the broader Chuck Norris mythology of transcendent capabilities.